CD44 and breast cancer: This hypothesis is supported by studies which have shown that CD44 expression can modulate chemotherapy response in breast cancer (e.g. [45]) although such reports have been primarily concerned with CD44, along with CD24, in the context of its role as a marker for intrinsically drug-resistant breast cancer stem cells.